Tramper dies walking the Milford Track The New Zealand Herald Sat, 28 Jan 2012 18:16 PM PST A tramper has died while walking the Milford Track in Fiordland.Police say the Japanese national appeared to have suffered a heart attack after falling.Senior Sergeant Dave Raynes of Invercargill police says the 63-year-old was... | My heart will go on - with this pump Straits Times Sat, 28 Jan 2012 17:50 PM PST The heart attack came like a bolt out of the blue, striking Dutchwoman Angelique Schoeber soon after the birth of her third child in Singapore. That was just over a year ago. Ms Schoeber, now 39, was so severely weakened that she had to be fitted with a mechanical heart to keep her alive. Related Stories Singapore, KL studying reciprocal pact for banks: Report Singapore is in a strong position ... | Jimmy âJunebugâ Jackson, 1957-2012 Washington City Paper Sat, 28 Jan 2012 17:22 PM PST Jimmy Jackson , the D.C.-based jazz drummer who was best known by his nickname "Junebug," died of congestive heart failure at about 1 a.m. today at Holy Cross Hospital in Silver Spring. Ten days earlier, he had turned 55. | Research links oral health, overall well-being North Shore News Sat, 28 Jan 2012 17:01 PM PST Dr. Nisha D'Mello of the University of Ottawa Heart Institute says the connection between dentists and cardiologists is important for patients. | Heart Defects Bill Proposed WSAZ NewsChannel 3 West Virginia Sat, 28 Jan 2012 16:51 PM PST About 20 other states have already passed legislation making special screenings for the condition mandatory so that doctors will catch the problem sooner and potentially save lives. | Amylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval Medical News Today Sat, 28 Jan 2012 16:30 PM PST On Friday, the US Food and Drug Administration finally approved Amylin Pharmaceutical's diabetes drug Bydureon, which provides glycemic control for diabetes type 2 in a once-weekly injection. The approval follows two earlier rejections in 2010, when the FDA asked the company to go back and carry out a new trial of the drug's effect on heart rhythm. The company describes Bydureon (exenatide ... | | |
|